Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Kessler's Northern New Jersey Traumatic Brain Injury System receives $2.2M NIDRR grant

The National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education awarded a $2.2 million federal grant to Kessler Foundation.

13 Dec 2012

Isis, Biogen Idec partner to discover and develop antisense drugs against neuromuscular disorders

Biogen Idec and Isis Pharmaceuticals, Inc. today announced that they have entered into a global collaboration agreement under which the companies will discover and develop antisense drugs against three undisclosed targets to treat neurological or neuromuscular disorders.

11 Dec 2012

Nuron Biotech announces acquisition of Meningitec from Pfizer

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced it has acquired from Pfizer Inc. Meningitec, which is a vaccine for the prevention of invasive disease caused by Neisseria meningitidis serogroup C.

10 Dec 2012

Genzyme receives EC approval for Thyrogen product label expansion

Genzyme, a Sanofi company, today announced it has received European Commission approval of a product label expansion for the use of Thyrogen (thyrotropin alfa) with a wider irradiation dose range for postoperative thyroid remnant ablation.

10 Dec 2012

Kessler Foundation to study effects of intellectual enrichment on cognitive decline in people with MS

The National Multiple Sclerosis (MS) Society awarded Victoria Leavitt, Ph.D., a $44,000 grant to study the effects of intellectual enrichment on cognitive decline in individual with multiple sclerosis.

7 Dec 2012

RedHill Biopharma completes $6.5M private placement

RedHill Biopharma Ltd., an Israeli biopharmaceutical company focusing primarily on development and acquisition of late clinical stage, patent-protected, new formulations and combinations of existing drugs, reported the completion of a private placement in a total amount of approximately $6.5 million.

6 Dec 2012

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Despite researchers' best efforts, no drug exists that can slow, halt or reverse the onslaught of Alzheimer's disease. A progressive and fatal neurodegenerative disorder, Alzheimer's has stolen the memories and livelihoods of millions-leaving patients and their families struggling to cope with the disease's devastating consequences. But today, scientists at the Gladstone Institutes propose a new research avenue that has the potential to change all that.

6 Dec 2012

Scientists develop MitoFish for in vivo studies of mitochondria transport in nerve cells

Scientists have demonstrated a new way to investigate mechanisms at work in Alzheimer's and other neurodegenerative diseases, which also could prove useful in the search for effective drugs. For new insights, they turned to the zebrafish, which is transparent in the early stages of its life. The researchers developed a transgenic variety, the "MitoFish," that enables them to see - within individual neurons of living animals - how brain diseases disturb the transport of mitochondria, the power plants of the cell.

6 Dec 2012

Vitamin D and women’s risk for multiple sclerosis

Women who have high vitamin D levels are at a decreased risk for developing multiple sclerosis, shows research.

5 Dec 2012

Reduced production of myelin may play role in development of mental illness: Study

Reduced production of myelin, a type of protective nerve fiber that is lost in diseases like multiple sclerosis, may also play a role in the development of mental illness, according to researchers at the Graduate School of Biomedical Sciences at Mount Sinai School of Medicine.

1 Dec 2012

German Research Foundation to establish new CRC at Mainz University Medical Center

On January 1, 2013, the German Research Foundation (DFG) will establish a new Collaborative Research Center (CRC) at the University Medical Center of Johannes Gutenberg University Mainz (JGU).

30 Nov 2012

Scientists define key underlying process implicated in multiple sclerosis

Scientists at the Gladstone Institutes have defined for the first time a key underlying process implicated in multiple sclerosis (MS)-a disease that causes progressive and irreversible damage to nerve cells in the brain and spinal cord. This discovery offers new hope for the millions who suffer from this debilitating disease for which there is no cure.

30 Nov 2012

Suvorexant may bring help for people with insomnia

A new drug may bring help for people with insomnia, according to a study published in the November 28, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Nov 2012

Reduction in myelin production may also play a role in development of mental illness

29 Nov 2012

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

UCB, a global biopharmaceutical company focusing on CNS and immunology treatment and research, is sponsoring key sets of VIMPAT® (lacosamide) C-V data at the 66th Annual Meeting of the American Epilepsy Society (AES) in San Diego, Calif., November 30 - December 4.

29 Nov 2012

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

John DeLuca, PhD, Vice President for Research and Training at Kessler Foundation, was named this year's recipient of the Medical Excellence Award by Musical Moments for MS. Dr. DeLuca will be honored at the 10th Anniversary of Musical Moments for MS on Tuesday, December 11 at NJPAC in Newark, NJ.

29 Nov 2012

IL17RC-mediated immune responses can be crucial in causing AMD

Changes in how genes in the immune system function may result in age-related macular degeneration (AMD), the leading cause of visual impairment in older adults, based on preliminary research conducted by National Institutes of Health (NIH) investigators.

29 Nov 2012

The Neuro clinician-scientists to further research on HIV/AIDS, Parkinson's

Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients' needs.

28 Nov 2012

Researchers aim to improve feeling of 'walking on marbles' for arthritis patients

Researchers at the University of Southampton are to undertake a new stage of a study aimed at improving the health and mobility of those suffering from the common complaint of 'walking on marbles' associated with Rheumatoid Arthritis (RA) in the feet.

28 Nov 2012

High-resolution real-time images show how nerves may be damaged during earliest stages of MS

High-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis. The results suggest that the critical step happens when fibrinogen, a blood-clotting protein, leaks into the central nervous system and activates immune cells called microglia.

28 Nov 2012

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Kessler's Northern New Jersey Traumatic Brain Injury System receives $2.2M NIDRR grant

Isis, Biogen Idec partner to discover and develop antisense drugs against neuromuscular disorders

Nuron Biotech announces acquisition of Meningitec from Pfizer

Genzyme receives EC approval for Thyrogen product label expansion

Kessler Foundation to study effects of intellectual enrichment on cognitive decline in people with MS

RedHill Biopharma completes $6.5M private placement

Investigators describe process by which apoE4 protein promotes development of Alzheimer's

Scientists develop MitoFish for in vivo studies of mitochondria transport in nerve cells

Vitamin D and women’s risk for multiple sclerosis

Reduced production of myelin may play role in development of mental illness: Study

German Research Foundation to establish new CRC at Mainz University Medical Center

Scientists define key underlying process implicated in multiple sclerosis

Suvorexant may bring help for people with insomnia

Reduction in myelin production may also play a role in development of mental illness

UCB to sponsor key sets of VIMPAT C-V data at 66th American Epilepsy Society annual meeting

Musical Moments for MS honors Kessler Foundation expert with Medical Excellence Award

IL17RC-mediated immune responses can be crucial in causing AMD

The Neuro clinician-scientists to further research on HIV/AIDS, Parkinson's

Researchers aim to improve feeling of 'walking on marbles' for arthritis patients

High-resolution real-time images show how nerves may be damaged during earliest stages of MS

Mastering RNA extraction for plant and fungal research – eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Mastering RNA extraction for plant and fungal research – eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in